Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21873/anticanres.15097 http://scihub22266oqcxt.onion/10.21873/anticanres.15097 34083306!ä!34083306 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Anticancer+Res 2021 ; 41 (6): 3127-3130 Nephropedia Template TP {{tp|p=34083306|t=2021. Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic |pdf=|usr=}}{{34083306}} gab.com Text Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic JO: Anticancer Res http://www.kidney.de/pget.php?&tw=1&pmid=34083306 #FOAvip BACKGROUND/AIM: To evaluate the diagnosis and treatment of prostate cancer (PCa) during 1 year of the COVID-19 pandemic. PATIENTS AND METHODS: The management of men with PCa during COVID-19 pandemic (March 2020-2021) was compared with the clinical activity of the 12 months before the COVID-19 pandemic (March 2019-2020). RESULTS: The number of clinical visits, prostate biopsy, and men enrolled in active surveillance was significantly lower during the COVID-19 pandemic (p<0.05); on the contrary, the number of cases with advanced (pT3b: 11.2 vs. 25.6%; nodal positive: 14.8 vs. 46.1%) and metastatic (5.9 vs. 9.3%) PCa increased. The number of open radical prostatectomies increased compared with the ones using a laparoscopic approach; moreover, more men were treated with external radiotherapy (25.1 vs. 54.2%). CONCLUSION: The guideline recommendations in the management of PCa should constantly adapt to the epidemiological evolution, but the overall cost of delayed diagnosis will increase in the near future. Twit Text FOAVip Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic ????Anticancer Res http://www.kidney.de/pget.php?&tw=1&pmid=34083306 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34083306 #FOAvip English Wikipedia <ref>{{Cite pmid|34083306}}</ref> Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic #MMPMID34083306 Pepe P; Pepe L; Pennisi M; Fraggetta F Anticancer Res 2021[Jun]; 41 (6): 3127-3130 PMID34083306show ga BACKGROUND/AIM: To evaluate the diagnosis and treatment of prostate cancer (PCa) during 1 year of the COVID-19 pandemic. PATIENTS AND METHODS: The management of men with PCa during COVID-19 pandemic (March 2020-2021) was compared with the clinical activity of the 12 months before the COVID-19 pandemic (March 2019-2020). RESULTS: The number of clinical visits, prostate biopsy, and men enrolled in active surveillance was significantly lower during the COVID-19 pandemic (p<0.05); on the contrary, the number of cases with advanced (pT3b: 11.2 vs. 25.6%; nodal positive: 14.8 vs. 46.1%) and metastatic (5.9 vs. 9.3%) PCa increased. The number of open radical prostatectomies increased compared with the ones using a laparoscopic approach; moreover, more men were treated with external radiotherapy (25.1 vs. 54.2%). CONCLUSION: The guideline recommendations in the management of PCa should constantly adapt to the epidemiological evolution, but the overall cost of delayed diagnosis will increase in the near future. |*Pandemics[MESH] |COVID-19/*epidemiology/virology[MESH] |Humans[MESH] |Male[MESH] |Prostatic Neoplasms/*diagnosis/pathology/*therapy[MESH]Prostate Cancer Diagnosis and Management During One Year of the COVID-(epmc).pdf DeepDyve Pubget Overpricing